Differential Discussions

Guest Series: Have We Cured Hemophilia? Part 1

28 min · 4. Juni 2025
Episode Guest Series: Have We Cured Hemophilia? Part 1 Cover

Beschreibung

Malissa & Dave are joined by George Fritsma. George Fritsma manages www.fritsmafactor.com [http://www.fritsmafactor.com], The Fritsma Factor, Your Interactive Hemostasis Resource for Precision BioLogic Inc., Dartmouth, NS; and “Coag Conversations” for BioMedica Diagnostics, Inc., Windsor, NS. If you want to learn more about George, please view this author interview: https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma [https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma]

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Differential Discussions-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

32 Folgen

Episode Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy Cover

Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy

Malissa & Dave are joined by David McGlasson to talk about chromogenic factor X assays and their use monitoring patients on warfarin. David McGlasson was a GS-13 staff researcher at the 59th Clinical Research Division at Lackland JBSA in Sant Antonio, TX until retirement. He holds degrees from the University of Incarnate Word and San Antonio College in San Antonio, TX and certification from the Gradwohl Schoolf of Laboratory Technique in Medical Technology. To read more about David, you can visit the Diapharma website https://diapharma.com/clot-club-david-mcglasson/ [https://diapharma.com/clot-club-david-mcglasson/] Here is the link to the article about chromogenic factor X assays: https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/ [https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/]

1. Apr. 202544 min